{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:23:38Z","timestamp":1761823418719,"version":"build-2065373602"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.maturitas.2011.07.021","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T04:58:18Z","timestamp":1317013098000},"page":"246-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management"],"prefix":"10.1016","volume":"70","author":[{"given":"Ronald","family":"Pyram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeti","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Gliwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2011.07.021_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","article-title":"Primary hyperparathyroidism: changes in the pattern of clinical presentation","volume":"1","author":"Mundy","year":"1980","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.maturitas.2011.07.021_bib0015","first-page":"N12","article-title":"The epidemiology of primary hyperparathyroidism in North America","volume":"17","author":"Melton","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/bjs.1800820723","article-title":"Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism","volume":"82","author":"Bartsch","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s002689900188","article-title":"Familial hyperparathyroidism without multiple endocrine neoplasia","volume":"21","author":"Huang","year":"1997","journal-title":"World J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0035","first-page":"F485","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mpsur.2007.09.010","article-title":"Hyperparathyroidism and hypocalcaemia","volume":"25","author":"Fisher","year":"2007","journal-title":"Surgery (Oxford)"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.jrn.2010.01.004","article-title":"Roles of calcium-sensing receptor and vitamin D receptor in the pathophysiology of secondary hyperparathyroidism","volume":"20","author":"McCann","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0055","doi-asserted-by":"crossref","first-page":"F665","DOI":"10.1152\/ajprenal.1999.277.5.F665","article-title":"Receptors for the PTH and PTHrP; their biological importance and functional properties","volume":"277","author":"Mannstadt","year":"1999","journal-title":"Am J Physiol-Ren Physiol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408360590886606","article-title":"The calcium-sensing receptor in normal physiology and the pathophysiology: a review","volume":"42","author":"Tfelt-Hansen","year":"2005","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2010.03.048","article-title":"The metabolism of 25-(OH) vitamin D3 by ostoeclasts and their precursors regulates the differentiation of osteoclasts","volume":"121","author":"Kogawa","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0070","first-page":"1736","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study","volume":"81","author":"Hsi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0075","first-page":"449","article-title":"Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors","volume":"6","author":"Rosenberg","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0080","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0002-9440(10)64086-2","article-title":"Deletion of 11q23 cyclin D1 overexpression are frequent aberrations in parathyroid adenomas","volume":"158","author":"Hemmer","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0085","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasia: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0095","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/me.2005-0116","article-title":"Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism","volume":"19","author":"Mallya","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0100","first-page":"2960","article-title":"Parathyroid MEN1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism","volume":"83","author":"Carling","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0105","first-page":"2627","article-title":"Alterations of MEN1 gene in sporadic parathyroid tumors","volume":"83","author":"Farnebo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2009.02105.x","article-title":"Brandi ML DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes","volume":"266","author":"Falchetti","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0115","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1097-0142(197708)40:2<846::AID-CNCR2820400238>3.0.CO;2-2","article-title":"Hyperparathyroidism in person treated with X-rays for tuberculous cervical adenitis","volume":"40","author":"Tisell","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0120","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/archinte.1989.00390080135030","article-title":"Therapeutic radiation and hyperparathyroidism. A case control study in Rochester","volume":"149","author":"Beard","year":"1989","journal-title":"Minn Arch Intern Med"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2307\/3578384","article-title":"Hyperparathyroidism among atomic bomb survivors in Hiroshima","volume":"130","author":"Fujiwara","year":"1992","journal-title":"Radiat Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/02841860500516618","article-title":"Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine","volume":"45","author":"Rasmuson","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0135","first-page":"2036","article-title":"Evaluation and management of primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.maturitas.2011.07.021_bib0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1744-9987.2011.00926.x","article-title":"Comparison between whole and intact parathyroid hormone assays","volume":"15","author":"Taniguchi","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0145","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med (Boston)"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0150","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(61)92251-6","article-title":"Effect of parathyroidectomy on the incidence of renal calculi","volume":"18","author":"Mcgeown","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0155","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0160","doi-asserted-by":"crossref","unstructured":"Suh JM, Cronan JJ, Monchik JM. Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? 2008;191:908\u201311.","DOI":"10.2214\/AJR.07.3160"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0165","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"June (6)","author":"Rejnmark","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third international workshop on the management of asymptomatic primary hyperthyroidism","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0175","first-page":"1","article-title":"Silverberg primary hyperparathyroidism in women: a tale of two cities \u2013 New York and Beijing","volume":"45","author":"Bilezikian","year":"2000","journal-title":"J Fertil Womens Med"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0185","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1046\/j.1365-2362.1998.00387.x","article-title":"Death risk factor analysis in primary hyperparathyroidism","volume":"28","author":"Hedback","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0190","first-page":"108","article-title":"Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977\u20131993 in Denmark World","volume":"28","author":"\u00d8gard","year":"2004","journal-title":"J Surg"},{"issue":"Suppl. 2","key":"10.1016\/j.maturitas.2011.07.021_bib0195","first-page":"N68","article-title":"Clinical presentation of primary hyperparathyroidism in Europe \u2013 nationwide cohort analysis on mortality from nonmalignant causes","volume":"17","author":"Nilsson","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0200","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1067\/msy.2001.118377","article-title":"Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years","volume":"130","author":"Lundgren","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","article-title":"Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population based study over five years","volume":"56","author":"Hagstrom","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0225","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2011-0238","article-title":"Mild primary hyperparathyroidism: Vitamin D deficiency and cardiovascular risk markers","volume":"96","author":"Farahnak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0230","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0235","first-page":"171","article-title":"Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study","volume":"162","author":"Dalberg","year":"1996","journal-title":"Eur J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0240","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0245","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF03346518","article-title":"Endothelial function and endothelial nitric oxide synthase intron 4a\/b polymorphism in primary hyperparathyroidism","volume":"32","author":"Ekmekci","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0255","first-page":"77","article-title":"Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin aldosterone systems","volume":"21","author":"Gennari","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0260","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","article-title":"Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up","volume":"82","author":"Stefenelli","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","article-title":"Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy","volume":"50","author":"Piovesan","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0270","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0275","article-title":"Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism","volume":"85","author":"Barletta","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0280","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-10-0201","article-title":"Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy","volume":"163","author":"Farahnak","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0290","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1067\/msy.2002.128692","article-title":"Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy","volume":"132","author":"Almqvist","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0295","first-page":"171","article-title":"Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study","volume":"162","author":"Dalberg","year":"1996","journal-title":"Eur J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0300","doi-asserted-by":"crossref","first-page":"974647","DOI":"10.1155\/2011\/974647","article-title":"Hypertension secondary to PHPT: cause or coincidence?","volume":"2011","author":"Schiffl","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0305","first-page":"457","article-title":"Hypertension in primary hyperparathyroidism in relation to histopathology","volume":"157","author":"Lind","year":"1991","journal-title":"J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0310","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/01.hjh.0000179764.40701.36","article-title":"Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men","volume":"23","author":"Jorde","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0315","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/HJH.0b013e32833bc5b4","article-title":"Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults","author":"Zhao","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0320","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-5793(91)80507-Y","article-title":"The effects of parathyroid hormone on L-type voltage-dependent calcium channel currents in vascular smooth muscle cells and ventricular myocytes are mediated by a cyclic AMP dependent mechanism","volume":"282","author":"Wang","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0303-7207(89)90231-1","article-title":"Parathyroid hormone acute vascular effect is mediated by decreased Ca2+ uptake and enhanced cAMP level","volume":"67","author":"Schleiffer","year":"1989","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0330","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0024-3205(88)90169-5","article-title":"Parathyroid hormone and calcium entry blockade in a vascular tissue","volume":"42","author":"Pang","year":"1988","journal-title":"J Life Sci"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0335","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0895-7061(00)00248-X","article-title":"Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism","volume":"13","author":"Kosch","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0340","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/msy.2099.101422","article-title":"Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy","volume":"129","author":"Nilsson","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0008-6363(98)00177-1","article-title":"Impairment of endothelium-independent vasodilation in patients with hypercalcemia","volume":"40","author":"Neunteufl","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0350","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","article-title":"The effect of surgical treatment on secondary hyperaldosteronism and the relative hyperinsulinemia in primary hyperparathyroidism","volume":"138","author":"Kovacs","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0355","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0026-0495(99)90075-6","article-title":"Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery","volume":"48","author":"Bernini","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0360","doi-asserted-by":"crossref","first-page":"309068","DOI":"10.1155\/2011\/309068","article-title":"Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism","volume":"2011","author":"Broulik","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0365","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0370","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/10641960903254471","article-title":"Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism","volume":"32","author":"Feldstein","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0375","first-page":"157","article-title":"Neurological and psychiatric disorders in primary hyperparathyroidism: the role of parathyroidectomy","volume":"79","author":"Casella","year":"2008","journal-title":"Ann Ital Chir"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0380","first-page":"338","article-title":"A retrospective analysis on the change in symptoms resulting from hyperparathyroidism following surgical intervention: allowing for the validation of a prospective surgical outcome study questionnaire","author":"Pasieka","year":"1995","journal-title":"World Congn Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0385","first-page":"942","article-title":"Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0390","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 35 item short form health survey (SF-36); conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0395","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0039-6060(99)70224-2","article-title":"Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels","volume":"125","author":"Burney","year":"1999","journal-title":"Surgery"},{"issue":"30","key":"10.1016\/j.maturitas.2011.07.021_bib0400","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 35 item short form health survey (SF-36); conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0405","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","article-title":"Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism","volume":"32","author":"Mihai","year":"2008","journal-title":"World Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0410","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1067\/msy.2002.128606","article-title":"Parathyroidectomy improved concentration and retentiveness in patients with primary hyperparathyroidism","volume":"132","author":"Prager","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0415","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.surg.2005.08.033","article-title":"Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism","volume":"138","author":"Roman","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0420","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/8756-3282(86)90020-7","article-title":"Bone remodeling and balance in primary hyperparathyroidism","volume":"7","author":"Eriksen","year":"1986","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0954-6820.1978.tb08406.x","article-title":"A tetracycline based evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism","volume":"204","author":"Melsen","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0430","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00003086-198201000-00040","article-title":"Effects of parathyroid hormone on remodeling of iliac trabecular bone packets in patients with primary hyperparathyroidism","volume":"162","author":"Charon","year":"1982","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0435","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0440","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0445","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-121-10-199411150-00003","article-title":"Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"211","author":"Grey","year":"1994","journal-title":"Ann Inter Med"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0450","first-page":"3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0455","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.5650090410","article-title":"Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy","volume":"9","author":"McDermott","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0460","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroidectomy","volume":"341","author":"Silverberg","year":"1999","journal-title":"NEJM"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0465","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0470","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00268-008-9720-8","article-title":"Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism","volume":"33","author":"VanderWalde","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0475","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2265.2003.01722.x","article-title":"Forearm bone density in primary hyperparathyroidism: long term follow-up with and without parathyroidectomy","volume":"58","author":"Rao","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0480","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0485","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0490","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-2007-1002158","article-title":"Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma","volume":"25","author":"Ishimura","year":"1993","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0495","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF03327373","article-title":"A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism","volume":"15","author":"Ammann","year":"2003","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0500","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0505","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study","volume":"87","author":"Parker","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0510","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0515","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1359\/jbmr.2003.18.10.1889","article-title":"Bisphosphonate therapy in primary hyperparathyroidism","volume":"18","author":"Hershman","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0520_1","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0520_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0525","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0530","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","article-title":"Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity","volume":"96","author":"Peacock","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0535","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0540","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0545","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03344140","article-title":"A very high incidence of low 25 hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism","volume":"29","author":"Boudou","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0550","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1210\/jcem.86.3.7327","article-title":"A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial","volume":"86","author":"Lips","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0555","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.surg.2005.09.018","article-title":"25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy","volume":"138","author":"Stewart","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0560","first-page":"3541","article-title":"Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism","volume":"85","author":"Kantorovich","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0565","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0570","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0575","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0580","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.surg.2008.06.032","article-title":"Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?","volume":"144","author":"Grubbs","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0585","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.maturitas.2011.07.021_bib0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(87)90417-7","article-title":"Tubular maximum for calcium reabsorption: lack of diagnostic usefulness in primary hyperparathyroidism and familial hypocalciuric hypercalcaemia","volume":"166","author":"Kent","year":"1987","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.maturitas.2011.07.021_bib0595","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/qjmed\/hcq261","article-title":"The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and Audit Research Study","volume":"104","author":"Yu","year":"2011","journal-title":"QJM"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:53:39Z","timestamp":1759913619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211002696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0378512211002696"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.07.021","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}